prof. dr hab. Joanna Mika
Strona główna
/
Instytut
/
Pracownicy
/
prof. dr hab. Joanna Mika
prof. dr hab. Joanna Mika
Dokonania naukowe
- Publikacje
- Granty
Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells.
Autorzy:
DOI: 10.3389/fncel.2015.00082
Date: 2015-01-01
Sinogenic complications involving orbit, frontal sinus, anterior and middle cranial fossa treated using endoscopic techniques.
Autorzy:
DOI:
Date: 2015-01-01
The Role of Some Chemokines from the CXC Subfamily in a Mouse Model of Diabetic Neuropathy
Autorzy: Magdalena Zychowska, Ewelina Rojewska, Dominika Pilat, Joanna Mika
DOI: 10.1155/2015/750182
Date: 2015-01-01
Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy
Autorzy: Katarzyna Popiolek-Barczyk, Natalia Kolosowska, Anna Piotrowska, Wioletta Makuch, Ewelina Rojewska, Agnieszka M. Jurga, Dominika Pilat, Joanna Mika
DOI: 10.1155/2015/676473
Date: 2015-01-01
Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model.
Autorzy:
DOI: 10.1016/j.jneuroim.2014.09.020
Date: 2014-12-01
Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats.
Autorzy:
DOI: 10.1016/j.neuropharm.2014.08.001
Date: 2014-11-01
Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
Autorzy:
DOI: 10.1016/j.pharep.2014.05.001
Date: 2014-10-01
Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain.
Autorzy:
DOI: 10.1016/j.pharep.2013.11.004
Date: 2014-06-01
Grant
OPUS 22 2021/43/B/NZ7/00230 Nowe strategie w farmakoterapii bólu neuropatycznego oparte na modulacji układu chemokin i jego wpływie na rozwój tolerancji opioidowej
15.07.2022 – 14.07.2026